BrightPath Biotherapeutics: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)

Feb 14 01:30 ET

BrightPath Biotherapeutics: Confirmation letter

Nov 8, 2024 01:35 ET

BrightPath Biotherapeutics: Half Year Report - Term 22 (2024/04/01 - 2025/03/31)

Nov 8, 2024 01:34 ET

BrightPath Biotherapeutics: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)

Nov 8, 2024 01:30 ET